Otsuka’s ADHD drug centanafadine is currently under review by the US FDA, with a PDUFA date of 24 July 2026.

Attention deficit hyperactivity disorder (ADHD) is a condition that can affect all stages of life. Medication is not the only treatment, but it is often the treatment that can make the most obvious ...

ADHD patients deserved a more consistent, safe and manageable medication experience. Imagining a better way forward, they ...

Are ADHD medications overprescribed in kids? Are too many kids taking ADHD medication? Understood examines the question of whether stimulant medications for ADHD are overprescribed, which has been ...

Researchers enrolled 39 people with biomarker-confirmed mild cognitive impairment tied to Alzheimer’s disease in a phase II ...

New ADHD medications come with higher price tags but not always better results. Here’s what actually matters when choosing the right treatment.

Amid rising diagnoses, a growing number of kids are getting prescriptions for ADHD medications — but the administered doses aren’t always accurate. Medication ...

A recent study that included 148,000 people diagnosed with attention deficit hyperactivity disorder (ADHD) found that taking prescribed ADHD medications was linked to lower rates of premature deaths ...

Attention-deficit/hyperactivity disorder, or ADHD, is one of the most common neurodevelopmental conditions in the United ...

But some commonly prescribed drugs interfere with these processes, making it harder to stay cool. Here are a few you should ...